Development of Targeted Alpha Therapy from Bench to Bedside

Development of Targeted Alpha Therapy from Bench to Bedside

This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical imaging and radiation sciences 2019-12, Vol.50 (4), p.S18-S20
Hauptverfasser: Morgenstern, Alfred, Bruchertseifer, Frank
Format: Artikel
Sprache:eng
Schlagworte:
actinium-225
alpha emitter
bismuth-213
clinical application
Targeted alpha therapy
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.
ISSN:1939-8654
1876-7982
DOI:10.1016/j.jmir.2019.06.046